Henkenberens C - Search Results

1

Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.

Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, Bach C, Becker-Schiebe M, Blana A, Bruns F, Buse S, Combs SE, Engels CL, Ezzibdeh E, Fiedler M, Fischer LA, Farzat M, Frismann A, Heck MM, Henkenberens C, Roesch MC, Käding C, Klautke G, Krausewitz P, Kuczyk MA, Leitsmann C, Lettmaier S, Mahjoub S, Manseck A, Medenwald D, Meyer A, Micke O, Moritz R, Ott M, Peters I, Pokupic S, Porres D, Preisser F, Reichel K, Schneider A, Schwentner C, Scobioala S, Truss M, Wegener D, Wezel F, Willborn K, Witt JH, Wittig A, Wittlinger M, Wolff HA, Zimmermanns V, Christiansen H. Harke NN, et al. Among authors: henkenberens c. PLoS One. 2022 Jun 14;17(6):e0269827. doi: 10.1371/journal.pone.0269827. eCollection 2022. PLoS One. 2022. PMID: 35700180 Free PMC article.

2

Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?

Henkenberens C, Meinecke D, Michael S, Bremer M, Christiansen H. Henkenberens C, et al. Strahlenther Onkol. 2015 Nov;191(11):845-54. doi: 10.1007/s00066-015-0885-4. Epub 2015 Aug 26. Strahlenther Onkol. 2015. PMID: 26307627

3

Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy.

Henkenberens C, Merseburger AS, Bengel F, Derlin T, Hueper K, Grünwald V, Christiansen H. Henkenberens C, et al. World J Urol. 2016 Sep;34(9):1239-45. doi: 10.1007/s00345-015-1733-y. Epub 2015 Nov 27. World J Urol. 2016. PMID: 26612676

4

Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.

Henkenberens C, Janssen S, Lavae-Mokhtari M, Leni K, Meyer A, Christiansen H, Bremer M, Dickgreber N. Henkenberens C, et al. Radiat Oncol. 2016 Feb 2;11:12. doi: 10.1186/s13014-016-0580-3. Radiat Oncol. 2016. PMID: 26830686 Free PMC article.

5

⁶⁸Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging.

Derlin T, Weiberg D, von Klot C, Wester HJ, Henkenberens C, Ross TL, Christiansen H, Merseburger AS, Bengel FM. Derlin T, et al. Among authors: henkenberens c. Eur Radiol. 2016 Dec;26(12):4345-4353. doi: 10.1007/s00330-016-4308-4. Epub 2016 Mar 24. Eur Radiol. 2016. PMID: 27011373

6

(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.

Henkenberens C, von Klot CA, Ross TL, Bengel FM, Wester HJ, Merseburger AS, Vogel-Claussen J, Christiansen H, Derlin T. Henkenberens C, et al. Strahlenther Onkol. 2016 Jul;192(7):431-9. doi: 10.1007/s00066-016-0982-z. Epub 2016 Jun 7. Strahlenther Onkol. 2016. PMID: 27272755 Clinical Trial. English.

7

Clinical Value of Squamous Cell Carcinoma Antigen (SCCAg) in Anal Cancer - A Single-Center Retrospective Analysis.

Henkenberens C, Toklu H, Tamme C, Bruns F. Henkenberens C, et al. Anticancer Res. 2016 Jun;36(6):3173-7. Anticancer Res. 2016. PMID: 27272844

8

Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging.

Schmuck S, Mamach M, Wilke F, von Klot CA, Henkenberens C, Thackeray JT, Sohns JM, Geworski L, Ross TL, Wester HJ, Christiansen H, Bengel FM, Derlin T. Schmuck S, et al. Among authors: henkenberens c. Clin Nucl Med. 2017 Jun;42(6):e286-e293. doi: 10.1097/RLU.0000000000001589. Clin Nucl Med. 2017. PMID: 28221194

9

Comparison of standard and delayed imaging to improve the detection rate of [⁶⁸Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer.

Schmuck S, Nordlohne S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, Ross TL, Bengel FM, Derlin T. Schmuck S, et al. Among authors: henkenberens c. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):960-968. doi: 10.1007/s00259-017-3669-5. Epub 2017 Mar 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28280856

10

⁶⁸Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy.

Henkenberens C, VON Klot CA, Ross TL, Bengel FM, Wester HJ, Katja H, Christiansen H, Derlin T. Henkenberens C, et al. Anticancer Res. 2017 Mar;37(3):1273-1279. doi: 10.21873/anticanres.11444. Anticancer Res. 2017. PMID: 28314292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters